Trial Profile
Study to evaluate the Neuroprotecive effect of Liraglutide in Type II Diabetes patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2018
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 17 Oct 2018 New trial record
- 05 Oct 2018 Results presented at the 54th Annual Meeting of the European Association for the Study of Diabetes